PD Andreas  Roos (PhD)
Translational Research in Neuromuscular Disorders

PD Dr. rer. nat. Andreas Roos

Germany:

Research Coordinator / Scientific Officer  - Dept. of Neuropediatrics, University of Duisburg-Essen 🡵

Project Manager - Institute of Neurology - Düsseldorf University Hospital, Heinrich-Heine-Universität Düsseldorf

International:

Visiting Professor - University of Belgrad

Emerging Myologist of the year 2023

Adjunct Professor - University of Ottawa 🡵

Invited Lecturer at University of Belgrade (Medical Faculty)


Welcome dear visitor

As senior scientist I am working in the field of translational medicine with a main focus on neurodegenerative and neuromuscular disorders.

In order to understand the etiology of these diseases and to obtain a full picture, my work focusses on the identification of the genetic cause as well as on the discovery of the related pathophysiological consequences. For the latter purpose, various biochemical techniques including different proteomic approaches are applied by making use of in vitro and in vivo models as well as of patient-derived material.

I'd like to invite you to discover my field activity and related projects.

Best regards

Andreas Roos

 

 

 

News

Feed

02.07.2025

Recently accepted

Lessons learned from a muscle study in Nail-Patella syndrome Orphanet Journal of Rare Diseases ~ Paul L, Hentschel A, Depienne C, Schänzer A, Kohlschmidt N, Schara-Schmidt U, Roos A, Kölbel H   mehr


28.06.2025

Recently published case report

Co-occurrence of myositis and neuropathy after anti-CD30 therapy in a late-adolescent Hodgkin lymphoma patient Acta Neuropathol Commun ~ Della Marina A, Rink L, Hentschel A, Schuendeln MM, Nelke...   mehr


11.06.2025

Recently published paper

Deciphering DST-associated disorders: biallelic variants affecting DST-b cause a congenital myopathy Brain ~ Jacob M, Koelbel H, Harrer P, Kopajtich R, Munot P, Achleitner MT, Badmann S, Brugger...   mehr


04.06.2025

Recently published review

Autosomal Recessive Cerebellar Ataxias: Translating Genes to Therapies Ann Neurol ~ Fogel BL, Klopstock T, Lynch DR, Maltecca F, Verma M, Minassian BA, Platt FM, Gonçalves DF, Puccio H, Roos A,...   mehr


31.05.2025

Recently pulished

276th ENMC International Workshop: recommendations on optimal diagnostic pathway and management strategy for patients with acute rhabdomyolysis worldwide Neuromuscul Disord ~ Kruijt N, Laforet P,...   mehr


07.04.2025

Recently published paper

Mitochondrial damage is associated with an early immune response in inclusion body myositis Brain ~ Kleefeld F, Cross E, Lagos D, Walli S, Schoser B, Hentschel A, Ruck T, Nelke C, Hahn K, Hathazi...   mehr


20.02.2025

Recently published paper

Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegeneration in spastic ataxia type...   mehr


19.02.2025

Recently published paper

Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle Brain ~ Malaichamy S, Idoux R, Polavarapu K, Šikić K, Holla E, Thompson R, Spendiff S, Schänzer A,...   mehr


13.02.2025

Recently accepted paper

Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome Acta Neuropathol Commun ~ Della Marina A, Koutsoulidou A, Natera-de Benito D, Tykocinski L-O,...   mehr


17.01.2025

Recently published paper

Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses Nat Med. ~ Laurie S, Steyaert W, de Boer E, Polavarapu K, Schuermans N, Sommer AK, Demidov G, Ellwanger K, Paramonov I,...   mehr


ältere >>